Assessment of comorbidity in lung cancer: How, why, and in whom?

Gajra Ajeet

首页> 外文期刊>Journal of geriatric oncology >Assessment of comorbidity in lung cancer: How, why, and in whom?

【24h】

Assessment of comorbidity in lung cancer: How, why, and in whom?

机译：肺癌合并症评估：如何，为什么以及在谁身上？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of geriatric oncology》 |2016年第2期|共4页
作者
Gajra Ajeet;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Comorbidity Assessment Using Charlson Comorbidity Index and Simplified Comorbidity Score and Its Association With Clinical Outcomes During First-Line Chemotherapy for Lung Cancer [J] . Singh Navneet, Singh Potsangbam Sarat, Aggarwal Ashutosh N., Clinical lung cancer . 2016,第3期

机译：肺癌一线化疗期间使用Charlson合并症指数和简化合并症评分的合并症评估及其与临床结果的关联
2. Assessment of comorbidity in lung cancer: How, why, and in whom? [J] . Gajra Ajeet Journal of geriatric oncology . 2016,第2期

机译：肺癌合并症评估：如何，为什么以及在谁身上？
3. Assessment of functional status, symptoms and comorbidity in elderly patients with advanced non-small-cell lung cancer (NSCLC) treated with gemcitabine and vinorelbine [J] . I. Maestu, J. Muñoz, L. Gómez-Aldaraví, Clinical and Translational Oncology . 2007,第2期

机译：吉西他滨和长春瑞滨治疗老年晚期非小细胞肺癌（NSCLC）患者的功能状态，症状和合并症的评估
4. Radiomics versus physician assessment for the early prediction of local cancer recurrence after stereotactic radiotherapy for lung cancer [C] . Sarah A. Mattonen, Carol Johnson, David A. Palma, Conference on medical imaging . 2016

机译：放射学与医师评估对肺癌进行立体定向放射治疗后局部癌症复发的早期预测
5. Anti-tumor Efficacy and Stability Assessment of a Peptidomimetic Targeting HER2 Receptor in Non-small Cell Lung Cancer [D] . Shrestha, Leeza . 2020

机译：非小细胞肺癌肽靶向HER2受体的抗肿瘤疗效和稳定性评估
6. Comorbidity Assessment in the National Cancer Database for Patients With Surgically Resected Breast Colorectal or Lung Cancer (AFT-01 -02 -03) [O] . Melisa L. Wong, Timothy L. McMurry, Jessica R. Schumacher, 2018

机译：国家癌症数据库中对手术切除的乳腺癌结肠直肠癌或肺癌患者的合并症评估（AFT-01-02-03）
7. 439P Comorbidity assessment using Charlson Comorbidity Index (CCI) and Simplified Comorbidity Score (SCS) and its association with clinical outcomes during first-line chemotherapy of lung cancer [O] . N. Singh, S.S. Potsangbam, A.N. Aggarwal, 2015

机译：439P使用Charlson合并症指数（CCI）和简化的合并症评分（SCS）及其与肺癌一线化疗临床结果的关联评估
8. Optimizing Treatment of Lung Cancer Patients with Comorbidities. [R] . Wisnivesky, J. 2017

机译：合并肺癌患者的优化治疗。

Assessment of comorbidity in lung cancer: How, why, and in whom?

著录项

相似文献

相关主题

期刊订阅